ResMed Return on Investment 2010-2024 | RMD
Current and historical return on investment (ROI) values for ResMed (RMD) over the last 10 years.
| ResMed ROI - Return on Investment Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | LT Investments & Debt | Return on Investment |
| 2024-03-31 | $1.21B | $5.63B | 21.59% |
| 2023-12-31 | $1.14B | $5.70B | 20.38% |
| 2023-09-30 | $1.15B | $5.60B | 20.63% |
| 2023-06-30 | $1.13B | $5.56B | 21.75% |
| 2023-03-31 | $1.11B | $5.51B | 22.95% |
| 2022-12-31 | $1.05B | $5.53B | 23.46% |
| 2022-09-30 | $1.01B | $4.22B | 25.18% |
| 2022-06-30 | $1.00B | $4.13B | 25.46% |
| 2022-03-31 | $0.99B | $3.95B | 26.13% |
| 2021-12-31 | $0.98B | $3.81B | 26.76% |
| 2021-09-30 | $0.95B | $3.82B | 26.26% |
| 2021-06-30 | $0.90B | $3.53B | 25.18% |
| 2021-03-31 | $0.89B | $3.43B | 24.43% |
| 2020-12-31 | $0.88B | $3.68B | 23.97% |
| 2020-09-30 | $0.86B | $3.72B | 23.53% |
| 2020-06-30 | $0.81B | $3.66B | 22.89% |
| 2020-03-31 | $0.71B | $3.62B | 20.49% |
| 2019-12-31 | $0.65B | $3.55B | 19.10% |
| 2019-09-30 | $0.61B | $3.33B | 18.44% |
| 2019-06-30 | $0.58B | $3.33B | 18.93% |
| 2019-03-31 | $0.61B | $3.35B | 21.54% |
| 2018-12-31 | $0.58B | $3.14B | 21.70% |
| 2018-09-30 | $0.57B | $2.42B | 30.06% |
| 2018-06-30 | $0.54B | $2.33B | 26.20% |
| 2018-03-31 | $0.52B | $2.88B | 23.24% |
| 2017-12-31 | $0.49B | 21.60% | |
| 2017-09-30 | $0.44B | $3.07B | 15.17% |
| 2017-06-30 | $0.43B | $3.04B | 15.06% |
| 2017-03-31 | $0.42B | $3.02B | 15.42% |
| 2016-12-31 | $0.41B | $2.58B | 16.72% |
| 2016-09-30 | $0.43B | $2.65B | 18.38% |
| 2016-06-30 | $0.43B | $2.57B | 20.04% |
| 2016-03-31 | $0.41B | $2.11B | 20.80% |
| 2015-12-31 | $0.41B | $1.93B | 21.21% |
| 2015-09-30 | $0.41B | $1.96B | 20.95% |
| 2015-06-30 | $0.41B | $1.89B | 20.62% |
| 2015-03-31 | $0.41B | $2.00B | 20.09% |
| 2014-12-31 | $0.41B | $2.04B | 19.82% |
| 2014-09-30 | $0.40B | $2.03B | 19.54% |
| 2014-06-30 | $0.41B | $2.06B | 20.47% |
| 2014-03-31 | $0.39B | $2.09B | 21.06% |
| 2013-12-31 | $0.38B | $2.08B | 21.49% |
| 2013-09-30 | $0.37B | $1.69B | 20.83% |
| 2013-06-30 | $0.35B | $1.61B | 19.14% |
| 2013-03-31 | $0.36B | $1.77B | 18.73% |
| 2012-12-31 | $0.34B | $2.05B | 17.57% |
| 2012-09-30 | $0.31B | $1.97B | 16.85% |
| 2012-06-30 | $0.30B | $1.86B | 16.46% |
| 2012-03-31 | $0.27B | $1.84B | 15.24% |
| 2011-12-31 | $0.26B | $1.79B | 14.72% |
| 2011-09-30 | $0.26B | $1.68B | 19.95% |
| 2011-06-30 | $0.27B | $1.83B | 29.88% |
| 2011-03-31 | $0.27B | $1.74B | 61.73% |
| 2010-12-31 | $0.27B | 78.12% | |
| 2010-09-30 | $0.25B | 37.44% | |
| 2010-06-30 | $0.24B | 24.03% | |
| 2010-03-31 | $0.23B | $1.36B | 17.62% |
| 2009-12-31 | $0.22B | $1.35B | 18.03% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $28.144B | $4.223B |
| ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $182.053B | 23.84 |
| Stryker (SYK) | United States | $129.729B | 31.07 |
| Boston Scientific (BSX) | United States | $112.966B | 35.98 |
| Medtronic (MDT) | Ireland | $101.722B | 15.23 |
| EssilorLuxottica (ESLOY) | France | $99.494B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $40.384B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.493B | 28.10 |
| Terumo (TRUMY) | Japan | $24.477B | 34.57 |
| Koninklijke Philips (PHG) | Netherlands | $23.276B | 18.48 |
| Zimmer Biomet Holdings (ZBH) | United States | $22.297B | 14.24 |
| Baxter (BAX) | United States | $17.081B | 12.15 |
| Insulet (PODD) | United States | $14.497B | 64.28 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.820B | 0.00 |
| Demant (WILYY) | Denmark | $9.620B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.758B | 25.37 |
| BellRing Brands (BRBR) | United States | $7.565B | 35.58 |
| Lantheus Holdings (LNTH) | United States | $5.636B | 14.04 |
| Haemonetics (HAE) | United States | $4.238B | 20.90 |
| GN Store Nord (GNNDY) | Denmark | $4.222B | 23.71 |
| Prestige Consumer Healthcare (PBH) | United States | $3.475B | 16.54 |
| Perrigo (PRGO) | Ireland | $3.467B | 10.51 |
| Neogen (NEOG) | United States | $3.457B | 33.25 |
| ICU Medical (ICUI) | United States | $2.893B | 25.53 |
| Envista Holdings (NVST) | United States | $2.832B | 11.69 |
| TG Therapeutics (TGTX) | United States | $2.774B | 78.04 |
| Green Thumb Industries (GTBIF) | United States | $2.724B | 53.33 |
| Agios Pharmaceuticals (AGIO) | United States | $2.476B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.246B | 12.47 |
| LeMaitre Vascular (LMAT) | United States | $1.847B | 54.13 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.784B | 0.00 |
| Warby Parker (WRBY) | United States | $1.611B | 0.00 |
| InMode (INMD) | Israel | $1.517B | 8.06 |
| Verano Holdings (VRNOF) | United States | $1.455B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.313B | 9.76 |
| AtriCure (ATRC) | United States | $1.108B | 0.00 |
| Owens & Minor (OMI) | United States | $1.051B | 9.16 |
| National Vision Holdings (EYE) | United States | $0.995B | 31.67 |
| BioLife Solutions (BLFS) | United States | $0.944B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.871B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.697B | 14.83 |
| Evolus (EOLS) | United States | $0.684B | 0.00 |
| PetIQ (PETQ) | United States | $0.659B | 21.31 |
| Surmodics (SRDX) | United States | $0.598B | 37.47 |
| VAREX IMAGING (VREX) | United States | $0.598B | 14.06 |
| Canopy Growth (CGC) | Canada | $0.508B | 0.00 |
| Quanterix (QTRX) | United States | $0.498B | 0.00 |
| Valneva SE (VALN) | France | $0.497B | 0.00 |
| ZimVie (ZIMV) | United States | $0.480B | 40.91 |
| Biote (BTMD) | United States | $0.458B | 10.56 |
| TerrAscend (TSNDF) | Canada | $0.426B | 0.00 |
| Jin Medical (ZJYL) | China | $0.398B | 0.00 |
| Cerus (CERS) | United States | $0.324B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.312B | 10.05 |
| Zynex (ZYXI) | United States | $0.287B | 39.26 |
| Ayr Wellness (AYRWF) | United States | $0.266B | 0.00 |
| MacroGenics (MGNX) | United States | $0.258B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.258B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.251B | 24.89 |
| Sanara MedTech (SMTI) | United States | $0.251B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.236B | 14.86 |
| Omeros (OMER) | United States | $0.229B | 0.00 |
| High Tide (HITI) | Canada | $0.182B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.166B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.156B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.152B | 21.57 |
| Capricor Therapeutics (CAPR) | United States | $0.148B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.132B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.130B | 0.00 |
| Veru (VERU) | United States | $0.117B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.109B | 0.00 |
| Brainsway (BWAY) | Israel | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.100B | 10.11 |
| InterCure (INCR) | Israel | $0.090B | 15.15 |
| Cellectar Biosciences (CLRB) | United States | $0.084B | 0.00 |
| Chimerix (CMRX) | United States | $0.080B | 0.00 |
| Bright Green (BGXX) | United States | $0.073B | 0.00 |
| MariMed (MRMD) | United States | $0.072B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.065B | 4.25 |
| Allurion Technologies (ALUR) | United States | $0.062B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.059B | 0.00 |
| Safety Shot (SHOT) | United States | $0.055B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.053B | 0.00 |
| Modular Medical (MODD) | United States | $0.051B | 0.00 |
| Apyx Medical (APYX) | United States | $0.049B | 0.00 |
| United-Guardian (UG) | United States | $0.043B | 15.47 |
| Cytosorbents (CTSO) | United States | $0.042B | 0.00 |
| ImmuCell (ICCC) | United States | $0.034B | 0.00 |
| Exagen (XGN) | United States | $0.032B | 0.00 |
| Nephros (NEPH) | United States | $0.022B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.022B | 0.00 |
| Agape ATP (ATPC) | $0.017B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.016B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.007B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.006B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |